Improving cancer immunotherapy by targeting the STATe of MDSCs

Cancer immunotherapy is a promising therapeutic avenue; however, in practice its efficacy is hampered by an immunosuppressive tumor microenvironment that consists of suppressive cell types like myeloid-derived suppressor cells (MDSCs). Eradication or reprogramming of MDSCs could therefore enhance cl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: de Haas, Nienke, de Koning, Coco, Spilgies, Lisanne, de Vries, I. Jolanda M., Hato, Stanleyson V.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006927/
https://ncbi.nlm.nih.gov/pubmed/27622051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1196312
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados